Home › Peripheral Arterial Disease › Tennessee › Nashville
Peripheral Arterial Disease clinical trials in Nashville, TN
6 studies for Peripheral Arterial Disease are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
RecruitingPhase 3
- Vanderbilt University Medical Center, Nashville
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- Vanderbilt University Medical Center, Nashville
SELUTION4BTK Trial
Recruiting
- Vanderbilt University Medical Center, Nashville
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Recruiting
- Vanderbilt University Medical Center, Nashville
Randomized Clinical Trial for Ewing Amputation in the VA
Recruiting
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Pounce™ Thrombectomy System Retrospective Registry
RecruitingObservational study
- Vanderbilt University Medical Center, Nashville
About Peripheral Arterial Disease
Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.
More about Peripheral Arterial Disease on MedlinePlus
Peripheral Arterial Disease trials in other cities
- Boston, MA10 studies
- Dallas, TX9 studies
- Cleveland, OH9 studies
- Chicago, IL9 studies
- Houston, TX8 studies
- Omaha, NE7 studies
- Gainesville, FL7 studies
- Minneapolis, MN6 studies
- Miami, FL6 studies
- Detroit, MI6 studies
- Aurora, CO6 studies
- New York City, NY6 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.